Literature DB >> 15274357

ProteinChip Array analysis of microdissected colorectal carcinoma and associated tumor stroma shows specific protein bands in the 3.4 to 3.6 kDa range.

Rene C Krieg1, Franz Fogt, Till Braunschweig, Paul C Herrmann, Volker Wollscheidt, Axel Wellmann.   

Abstract

Multiple pathways of carcinogenesis have been associated with colorectal carcinomas, including the adenoma-carcinoma sequence. The non polyposis coli gene has also been implicated in the pathogenesis of these tumors. Identification of the epithelial-mesenchymal interaction may help in understanding the pathways of invasion and may lead to the development of new, non-invasive tools for the diagnosis and prognosis of colon carcinomas. A ProteinChip Array technology (SELDI=Surface Enhanced Laser Desorption Ionization) has been developed enabling analysis and profiling of complex protein mixtures from a few cells. This study describes the protein analysis of approximately 500-1000 freshly obtained cells from normal and malignant colonic epithelium and its associated stroma by SELDI-TOF-MS (Surface Enhanced Laser Desorption Ionization Time-of-Flight Mass Spectrometry). Pure cell populations of normal and malignant epithelium as well as stroma (without tumor cells) were selected by microdissection from 9 patients. A pattern of 3 peptides of 3.48, 3.55 and 3.6 kDa, which were increased in the colon tumor epithelium and stroma compared to associated normal colon and stroma in all 9 patients, was observed. Coupling microdissection with SELDI represents a powerful tool to identify cell and tumor specific proteins and to understand molecular events underlying the invasive event in colorectal carcinomas. The presence of certain proteins in invasive carcinomas may lead to the development of non invasive biomarkers for the identification or detection of recurrence of colorectal malignancies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15274357

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.

Authors:  Judith Y M N Engwegen; Helgi H Helgason; Annemieke Cats; Nathan Harris; Johannes M G Bonfrer; Jan H M Schellens; Jos H Beijnen
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

Review 2.  [Identification of biomarkers and therapeutic targets for renal cell cancer using ProteinChip technology].

Authors:  K Junker; F von Eggeling; J Müller; T Steiner; J Schubert
Journal:  Urologe A       Date:  2006-03       Impact factor: 0.639

3.  Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).

Authors:  Huixiao Hong; Yvonne Dragan; Joshua Epstein; Candee Teitel; Bangzheng Chen; Qian Xie; Hong Fang; Leming Shi; Roger Perkins; Weida Tong
Journal:  BMC Bioinformatics       Date:  2005-07-15       Impact factor: 3.169

Review 4.  Application of proteomics in the study of tumor metastasis.

Authors:  Zhen Cai; Jen-Fu Chiu; Qing-Yu He
Journal:  Genomics Proteomics Bioinformatics       Date:  2004-08       Impact factor: 7.691

5.  Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.

Authors:  Kristyna Brozkova; Eva Budinska; Pavel Bouchal; Lenka Hernychova; Dana Knoflickova; Dalibor Valik; Rostislav Vyzula; Borivoj Vojtesek; Rudolf Nenutil
Journal:  Breast Cancer Res       Date:  2008-05-29       Impact factor: 6.466

6.  TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms.

Authors:  Wei Bin Fang; Benford Mafuvadze; Min Yao; An Zou; Mike Portsche; Nikki Cheng
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.